Acadia Healthcare Company (ACHC) : 12 analysts are covering Acadia Healthcare Company (ACHC) and their average rating on the stock is 1.25, which is read as a Strong Buy. 10 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. Acadia Healthcare Company (ACHC) also receives 1 more Buy recommendations from analysts who believe that the stock will do well going forward. A Zacks Investment Research rank of 4, which recommends a Sell affirms that they expect a large upside in the stock from the current levels. A total of 1 brokerage firms believe that the stock is fairly valued, hence they advise a Hold on the stock.
Acadia Healthcare Company (ACHC) : Average target price received by Acadia Healthcare Company (ACHC) is $79.4 with an expected standard deviation of $11. The most aggressive target on the stock is $100, whereas the most downbeat target is $65. 10 financial analysts are currently covering the stock.
For the current week, the company shares have a recommendation consensus of Buy.
Acadia Healthcare Company (NASDAQ:ACHC): During Tuesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $54.88 and $54.60 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $56.53. The buying momentum continued till the end and the stock did not give up its gains. It closed at $56.46, notching a gain of 3.67% for the day. The total traded volume was 1,089,596 . The stock had closed at $54.46 on the previous day.
Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities. It operates in two segments: U.S. Facilities and U.K. Facilities. Its U.S. Facilities and services are classified into categories, which includes acute inpatient psychiatric facilities; specialty treatment facilities; residential treatment centers; and outpatient community-based services. In the United Kingdom, it provides inpatient services through mental health hospitals and care homes. In addition to these services, it also operates a U.K. division to provide EAP to organizations. The Company operated approximately 78 behavioral healthcare facilities with over 5,800 beds in approximately 24 states, the United Kingdom and Puerto Rico.